Events & Presentations

Upcoming Events
Date Event Details Remind Me
Apr 3 - Apr 4, 2023
7th Complement UK Training Course and Symposium
Archived Events
Date Event Details
Oct 4, 2021 4:30 PM EDT
Chardan's 5th Annual Genetic Medicines Conference
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation
Sep 29, 2021 9:20 AM EDT
2021 Cantor Virtual Global Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Sep 14, 2021 4:55 PM EDT
Baird's 2021 Global Healthcare Conference
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation
Sep 13, 2021 7:00 AM EDT
HC Wainwright 23rd Annual Global Investment Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Sep 9, 2021
Citi’s 16th Annual BioPharma Virtual Conference
Arrowhead management will host a day of virtual investor meetings
Aug 5, 2021 4:30 PM EDT
Arrowhead Pharmaceuticals 2021 Third Quarter Results
Jun 25, 2021
28th Annual FSHD Society International Research Congress
Jonathan Van Dyke, Ph.D., Arrowhead’s senior scientist II of biology, will deliver an oral presentation on the preclinical development of ARO-DUX4
Jun 23 - Jun 26, 2021
The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL)

Title: ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH
Authors: Edward Gane, et al.
Type: Late-Breaking Poster
Date and Time: June 23, 2021 at 8:00 CEST

Title: Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors
Authors: Edward Gane, et al.

Type: Oral Presentation
Date and Time: June 25, 2021 at 15:15 CEST

Title: ARO-AAT an investigational RNAi therapeutic demonstrates improvement in liver fibrosis with reduction in intra-hepatic Z-AAT burden
Authors: Pavel Strnad, et al.
Type: Late-Breaking Oral Presentation
Date and Time: June 26, 2021 at 12:15 CEST
 

Jun 22, 2021
LifeSci Partners Genetic Medicines Summit 2021
Members of Arrowhead management will participate in a fireside chat presentation
Jun 17, 2021
Virtual Dana-Farber Harvard Cancer Center Symposium on HIF, VHL, and Kidney Cancer
So Wong, Ph.D., Arrowhead’s senior director of biology, will deliver an oral presentation on the preclinical development of ARO-HIF2